Treatment was successful despite pre-existing multiple life-threatening infections; in particular, during blockade of IFNγ with emapalumab, all infections resolved with supportive antimicrobial medications and cessation of etoposide and dexamethasone. The gene discussed is IFNG; the disease is infection.